Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction—meta-analysis of pooled data from randomised clinical trials

The results of our meta-analysis of patients with mild to moderate dementia who had previously had a cerebral infarction verified by neuroimaging showed statistically significant and clinically relevant benefits of EGb 761. The drug was shown to be safe and well tolerated and is a promising treatment option for patients developing dementia after cerebral infarction. Further dedicated clinical trials are needed to confirm these results.